NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on: December 20,2023

NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer

by ECOG-ACRIN Cancer Research GroupDr. Komal Jhaveri of Memorial Sloan Kettering Cancer Center in New York is the lead researcher for the NCI-MATCH precision medicine clinical trial's treatment ar

Updated on:December 20,2023

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on: August 25,2025

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on:August 25,2025

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel

Updated on: December 27,2023

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel

Updated on:December 27,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on: December 27,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on:December 27,2023

Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

by Rutgers Cancer Institute of New JerseyCredit: Unsplash/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehe

Updated on: December 20,2023

Investigators explore impact of cigarette smoking and alcohol consumption on Black breast cancer survivors

by Rutgers Cancer Institute of New JerseyCredit: Unsplash/CC0 Public DomainInvestigators from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehe

Updated on:December 20,2023

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on: March 20,2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

by Fred Hutchinson Cancer CenterCredit: CC0 Public DomainA blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detect

Updated on:March 20,2024

Cancer: People living in England's poorest areas at higher risk of death—new study

by David Nelson,The ConversationCredit: Pixabay/CC0 Public DomainNationally, the risk of dying from most cancers is falling thanks to improvements inscreening, diagnostics and treatment. B

Updated on: December 30,2023

Cancer: People living in England's poorest areas at higher risk of death—new study

by David Nelson,The ConversationCredit: Pixabay/CC0 Public DomainNationally, the risk of dying from most cancers is falling thanks to improvements inscreening, diagnostics and treatment. B

Updated on:December 30,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Updated on: December 22,2023

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Updated on:December 22,2023

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on: January 08,2024

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Updated on:January 08,2024

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on: December 27,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on:December 27,2023

New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

byWaseda UniversityDetection of HPV16 E7 oncoproteins in urine samples using ultrasensitive enzyme-linked immunosorbent assay Image caption: Researchers have now validated a noninvasive method f

Updated on: July 09,2024

New urine-based test shows promise in making cervical cancer screening more accessible and less invasive

byWaseda UniversityDetection of HPV16 E7 oncoproteins in urine samples using ultrasensitive enzyme-linked immunosorbent assay Image caption: Researchers have now validated a noninvasive method f

Updated on:July 09,2024

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on: December 20,2023

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on:December 20,2023